Sticking to medication can be thought of as a decision making process that involves the consideration of the pros and cons of change. It involves evaluation on self-efficacy to change and attitudes held about the efficacy of medication regimens. This can be difficult to many HIV positive patients A quality patient-provider relationship can also be identified as an important source of adhering to HIV medications. Understanding the predicament of the majority of HIV positive persons, conceived a breakthrough in HIV treatment administration. Surely, there are ways anyone can do to better adhere to ones treatment regimens but Vonavir/Atripla took all the burden away.

Atripla is the first ever once-daily single tablet regimen (STR) for adult HIV infection. It was approved by the Food and Drugs Administration on July 12, 2006. Atripla is the result of unprecedented effort between Gilead Sciences the manufacturer of Emtriva and Viread, with Bristol-Myers Squibb the maker of Sustiva.This one-pill-once a day pill combines the active ingredients of Sustiva (efavirenz) a Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) with Emtriva (emtricitabine) and Veriad (tenofovir disoproxil fumarate), two Nucleoside Reverse transcriptase Inhibitor (NRTI). It is highly recommended to be taken at bedtime to improve tolerability of the nervous system and it is not recommended for HIV patients under 18 years old.

Common side effects of Atripla are tiredness, dizziness, stomach and intestinal upset and skin discoloration. More severe side effects are hallucination and sleeplessness. According to the official website of Atripla, medications that should not be taken with Atripla are: Hizmanal (astimizole), Vascor (bepridel), Propulsid (cisapride), Versed (midazolam), Orap (pimozide), Halcion (triazolam), or ergot derivatives. Discuss any other HIV or hepatitis medication you are taking  with your doctor to avoid complication. Atripla can significantly simplify HIV/AIDS medication regimen by easing the pill burden, promoting adherence and thus reducing potential development of viral resistance to the drugs. This may result in longer term effectiveness of the drug regimen. Learn more, early symptoms of HIV